Synapse Open Synapse
Science

U.S. approval of cheap, generic HIV prevention shot may boost global rollout

Science Magazine ·

Indian company pledges to sell injectable lenacapavir in low- and middle-income countries for only $40 a year

Latest from Science Magazine